Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DRC COMP2

Next Previous
Drug Profile

DRC COMP2

Alternative Names: DCR-COMP-2

Latest Information Update: 28 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dicerna Pharmaceuticals
  • Developer Alexion AstraZeneca Rare Disease; Dicerna Pharmaceuticals
  • Class Hepatoprotectants; Small interfering RNA
  • Mechanism of Action Complement activation inhibitors; RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Liver disorders

Most Recent Events

  • 28 Feb 2026 No recent reports of development identified for preclinical development in Liver-disorders in USA (Parenteral)
  • 31 Jan 2022 Dicerna pharmaceutical enters into licensing agreement with Alexion AstraZeneca Rare Disease for the development of RNA interference (RNAi) therapies (Dicerna Pharmaceutical pipeline; January 2022)
  • 20 Jan 2022 Alexion Pharmaceuticals was acquired by AstraZeneca and changed its name to Alexion AstraZeneca Rare Disease

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top